These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8455077)

  • 1. Reproducibility of repeated measures of carbon-11-raclopride binding in the human brain.
    Volkow ND; Fowler JS; Wang GJ; Dewey SL; Schlyer D; MacGregor R; Logan J; Alexoff D; Shea C; Hitzemann R
    J Nucl Med; 1993 Apr; 34(4):609-13. PubMed ID: 8455077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term stability of neurotransmitter activity investigated with 11C-raclopride PET.
    Schlösser R; Brodie JD; Dewey SL; Alexoff D; Wang GJ; Fowler JS; Volkow N; Logan J; Wolf AP
    Synapse; 1998 Jan; 28(1):66-70. PubMed ID: 9414019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproducibility of repeated measures of endogenous dopamine competition with [11C]raclopride in the human brain in response to methylphenidate.
    Wang GJ; Volkow ND; Fowler JS; Logan J; Pappas NR; Wong CT; Hitzemann RJ; Netusil N
    J Nucl Med; 1999 Aug; 40(8):1285-91. PubMed ID: 10450679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping of central D2 dopamine receptors in man using [11C]raclopride: PET with anatomic standardization technique.
    Ito H; Okubo Y; Halldin C; Farde L
    Neuroimage; 1999 Feb; 9(2):235-42. PubMed ID: 9927552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new PET ligand for the dopamine transporter: studies in the human brain.
    Volkow ND; Ding YS; Fowler JS; Wang GJ; Logan J; Gatley SJ; Schlyer DJ; Pappas N
    J Nucl Med; 1995 Dec; 36(12):2162-8. PubMed ID: 8523098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects.
    Dewey SL; Smith GS; Logan J; Brodie JD; Simkowitz P; MacGregor RR; Fowler JS; Volkow ND; Wolf AP
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11816-20. PubMed ID: 8265632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of blood flow on [11C]raclopride binding in the brain: model simulations and kinetic analysis of PET data.
    Logan J; Volkow ND; Fowler JS; Wang GJ; Dewey SL; MacGregor R; Schlyer D; Gatley SJ; Pappas N; King P
    J Cereb Blood Flow Metab; 1994 Nov; 14(6):995-1010. PubMed ID: 7929663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic analysis of central [11C]raclopride binding to D2-dopamine receptors studied by PET--a comparison to the equilibrium analysis.
    Farde L; Eriksson L; Blomquist G; Halldin C
    J Cereb Blood Flow Metab; 1989 Oct; 9(5):696-708. PubMed ID: 2528555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decrease in human striatal dopamine D2 receptor density with age: a PET study with [11C]raclopride.
    Rinne JO; Hietala J; Ruotsalainen U; Säkö E; Laihinen A; Någren K; Lehikoinen P; Oikonen V; Syvälahti E
    J Cereb Blood Flow Metab; 1993 Mar; 13(2):310-4. PubMed ID: 8436624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging endogenous dopamine competition with [11C]raclopride in the human brain.
    Volkow ND; Wang GJ; Fowler JS; Logan J; Schlyer D; Hitzemann R; Lieberman J; Angrist B; Pappas N; MacGregor R
    Synapse; 1994 Apr; 16(4):255-62. PubMed ID: 8059335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution volume ratios without blood sampling from graphical analysis of PET data.
    Logan J; Fowler JS; Volkow ND; Wang GJ; Ding YS; Alexoff DL
    J Cereb Blood Flow Metab; 1996 Sep; 16(5):834-40. PubMed ID: 8784228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereoselective binding of 11C-raclopride in living human brain--a search for extrastriatal central D2-dopamine receptors by PET.
    Farde L; Pauli S; Hall H; Eriksson L; Halldin C; Högberg T; Nilsson L; Sjögren I; Stone-Elander S
    Psychopharmacology (Berl); 1988; 94(4):471-8. PubMed ID: 3131792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GABAergic inhibition of endogenous dopamine release measured in vivo with 11C-raclopride and positron emission tomography.
    Dewey SL; Smith GS; Logan J; Brodie JD; Yu DW; Ferrieri RA; King PT; MacGregor RR; Martin TP; Wolf AP
    J Neurosci; 1992 Oct; 12(10):3773-80. PubMed ID: 1357114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Striatal binding of the PET ligand 11C-raclopride is altered by drugs that modify synaptic dopamine levels.
    Dewey SL; Smith GS; Logan J; Brodie JD; Fowler JS; Wolf AP
    Synapse; 1993 Apr; 13(4):350-6. PubMed ID: 8480281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging dopamine release with Positron Emission Tomography (PET) and (11)C-raclopride in freely moving animals.
    Patel VD; Lee DE; Alexoff DL; Dewey SL; Schiffer WK
    Neuroimage; 2008 Jul; 41(3):1051-66. PubMed ID: 18442926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproducibility of 11C-raclopride binding in the rat brain measured with the microPET R4: effects of scatter correction and tracer specific activity.
    Alexoff DL; Vaska P; Marsteller D; Gerasimov T; Li J; Logan J; Fowler JS; Taintor NB; Thanos PK; Volkow ND
    J Nucl Med; 2003 May; 44(5):815-22. PubMed ID: 12732684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of endogenous dopamine on extrastriatal [¹¹C]FLB 457 binding measured by PET.
    Okauchi T; Suhara T; Maeda J; Kawabe K; Obayashi S; Suzuki K
    Synapse; 2001 Aug; 41(2):87-95. PubMed ID: 11400175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of amphetamine-induced changes in [11C]raclopride binding with continuous infusion.
    Carson RE; Breier A; de Bartolomeis A; Saunders RC; Su TP; Schmall B; Der MG; Pickar D; Eckelman WC
    J Cereb Blood Flow Metab; 1997 Apr; 17(4):437-47. PubMed ID: 9143226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of carbon-11-labeled raclopride in rat striatum using positron emission tomography.
    Hume SP; Myers R; Bloomfield PM; Opacka-Juffry J; Cremer JE; Ahier RG; Luthra SK; Brooks DJ; Lammertsma AA
    Synapse; 1992 Sep; 12(1):47-54. PubMed ID: 1411963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET study on striatal dopamine D2 receptor changes during the progression of early Parkinson's disease.
    Rinne JO; Laihinen A; Rinne UK; Någren K; Bergman J; Ruotsalainen U
    Mov Disord; 1993 Apr; 8(2):134-8. PubMed ID: 8474478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.